3rd Quarter - Report
THE DUBERSTEIN GROUP INC. for PHRMA INC.
Client
Income
$100,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare rebates/Mediare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Copyright/Patent/Trademark CPT
Patent reform - HR 3309, Innovation Act; S 1720, Patent Transparency and Improvements Act of 2013; S 1013, Patent Abuse Reduction Act of 2013; S 866, Patent Quality Improvement Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.